Marco Brughera

This profile gathers the share dealings of Marco Brughera in Fennec Pharmaceuticals Inc. In total, 5 filings cover trades dated from 10 August 2016 to 15 September 2026.

Market trades split into 1 purchase (€20k) and 2 sales (€120k). On balance, insiders were net sellers of €100k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise. 2026 to date brings 1 purchase and 2 sales.

The newest entry dates from 18 September 2026: an open-market sale of €100k, in Fennec Pharmaceuticals Inc. The latest purchase dates back some time: it was published 52 days ago, on 18 September 2026. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.